Weekend reads: “Weaponized transparency;” fighting academic spam with humor; NIH cracks down

Before we present this week’s Weekend Reads, a question: Do you enjoy our weekly roundup? If so, would you consider a tax-deductible donation of $25, or a recurring donation of an amount of your choosing, to support it? Thanks in advance.

The week at Retraction Watch featured a major case of misconduct at The Ohio State University, the retraction of a much-criticized paper claiming to show “off-target” mutations when using CRISPR, and how fallout from a stem cell scandal ensnared a Nobel Prize winner. Here’s what was happening elsewhere:

Like Retraction Watch? You can make a tax-deductible contribution to support our growth, follow us on Twitter, like us on Facebook, add us to your RSS reader, sign up for an email every time there’s a new post (look for the “follow” button at the lower right part of your screen), or subscribe to our daily digest. If you find a retraction that’s not in our database, you can let us know here. For comments or feedback, email us at team@retractionwatch.com.

One thought on “Weekend reads: “Weaponized transparency;” fighting academic spam with humor; NIH cracks down”

  1. The report that human trials of a stem cell tracheal scaffolding technique have received extensive ethical approval and funding must be an April Fools prank. Animal studies by the same group are suspect, and Macchiarini almost single handedly destroyed the reputation of the Karolinska Institutet with previous clinical “experiments.” Or maybe the whole scenario is a cruel script submitted to Monty Python’s Flying Circus.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.